Egg Donor Form | NYU Langone Health
Fill out this form if you are interested in becoming an egg donor with the NYU Langone Fertility Center.
Egg Donor Program | NYU Langone Health
The Egg Donor Program at NYU Langone Fertility Center matches egg donors with women who are unable to use their own eggs to achieve pregnancy.
Egg Freezing & Embryo Banking | NYU Langone Health
The Egg Freezing and Embryo Banking Program at the NYU Langone Fertility Center helps preserve fertility.
Egg Freezing at NYU Langone Reproductive Specialists of New York | NYU Langone Health
At NYU Langone Reproductive Specialists of New York, we help women, men, and couples preserve their fertility.
Elacestrant versus Standard Endocrine Therapy in Women and Men with Node-positive Estrogen Receptor-positive HER2-negative Early Breast Cancer with High Risk of Recurrence A Global Multicenter Randomized Open-label Phase 3 Study (ELEGANT)
This is a phase 3 study, comparing the new medicine called Elacestrant (selective estrogen receptor degrader) with standard hormonal treatments in patients with ER-positive/HER2-negative early breast cancer who have previously received at least 2 years of hormonal treatment after their surgery or first breast cancer treatment and are currently receiving hormonal treatment. Patients will be divided into two groups. One group will receive the study medicine elacestrant, and the other group will continue the standard hormonal treatment they are already receiving. All patients will have their blood samples taken to see how their bodies are handling the medicine. Doctors will perform special scans at different times throughout the study to see how the patients are doing and if the study medicine is working better than the standard treatment. All patients will be closely watched for side effects and will be followed for 28 (+7) days after their last treatment.
Elbow Sprains & Strains | NYU Langone Health
Doctors at NYU Langone diagnose elbow sprains and strains and offer treatments to help you heal.
Electroconvulsive Therapy for Bipolar Disorder | NYU Langone Health
Doctors at NYU Langone may prescribe electroconvulsive therapy for adults with bipolar disorder that does not respond to other treatments.
Electroconvulsive Therapy for Depression | NYU Langone Health
Doctors at NYU Langone may prescribe electroconvulsive therapy for people with severe depression who have not responded to other treatments.
Electroconvulsive Therapy Program at Inpatient Psychiatry at Tisch Hospital | NYU Langone Health
The Electroconvulsive Therapy Program at NYU Langone’s Tisch Hospital provides inpatient and outpatient treatment and care.
Electronic cigarettes as a harm reduction strategy in people living with HIV/AIDS
People living with HIV/AIDS (PLWHA) are known to have exceptionally higher rate of cigarette smoking and very low quit rates compared to the general population. Although a primary rationale for conducting this study is reducing health disparities among PLWHA, there is a potential benefit of the proposed work from a prevention perspective given that combustible cigarette smoking is an independent risk factor for non-adherence to ART and may decrease the effectiveness of HAART (1-5). Smoking-related illnesses are leading causes of non-HIV/AIDS-related deaths among People Living with HIV/AIDS (PLWHA). (6) There are major yet unique barriers to combustible cigarette (CC) cessation among PLWHA.7? Additionally, FDA approved CC cessation medications have not been effective with this population. (8-11) Electronic cigarettes (E-cigarettes) could help people reduce the harm of CC through reductions in number of Cigarettes per Day (CPD) or quitting CC completely by addressing both nicotine and behavioral dependence. (12-14) A harm reduction approach may be more appropriate to use with PLWHA.15 This mixed-methods study’s purpose is to identify barriers and facilitators, as well as assess preliminary effectiveness of e-cigarettes as a harm reduction strategy among PLWHA.